Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xerogenic Potential of the Most Frequently Prescribed Psychiatric Drugs

NCT06920472 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT06920472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06920472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xerogenic Potential of the Most Frequently Prescribed Psychiatric Drugs
Lead sponsor
Semmelweis University
Phase
Observational
Overall status
Completed
Start date
January 1, 2013
Completion date
January 1, 2018
Enrollment
361 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psychiatric disorders, xerostomia due to hyposecretion of salivary gland